Aşağıda bir kısmını gördüğünüz bu dokümana sadece Profesyonel +
pakete abone olan üyelerimiz erişebilir.
4.2. BIOTECHNOLOGY DIRECTIVE
Diversely from the Biotechnology Directive, the EPO is an outcome of a multinational…
On the other hand, the rationale behind the Biotechnology Directive is completely…
Another rationale behind the Biotechnology Directive was the economic growth in Europe.…
“… the Directive should allow inventors … to benefit from patent protection as effective…
In other words, the concerns prompted a legislative step in the EU, and drafting…
The first draft of the Directive raised much concern. First of all, The Economic…
After the Commission made amendments, this time, the Council was dissatisfied, and…
However, the difficulties did not end in 1998. The Directive was challenged by the…
Before moving onto hESC patent exclusions in Europe, it is also worth mentioning…
4.1. APPLICATION ROUTES IN EUROPE
4.3. CRITERIA AND EXCLUSIONS
EN
TR
